CH&LA Fundraising Mission Raises $270,000 for Blood Cancer Patients

CH&LA Fundraising Mission Raises $270,000 for Blood Cancer Patients
0
(0)

The Leukemia & Lymphoma Society (LLS) and the California Hotel & Lodging Association (CH&LA) have joined efforts at the CH&LA Fundraising Mission, the first initiative of its kind to raise donations and support research in an attempt to find a cure for blood cancers. The partners announced that the CH&LA Fundraising Mission is now completed, after four months of campaign and more than $270,000 collected.

The funds will help patients who suffer from blood cancer in California and their families, supporting both research and educational programs or assistance services.

Among the services supported by LLS is the Co-Pay Assistance Program, designed to offer patients assistance to pay insurance premiums and other obligations. Since its foundation in 1949, the LLS has focused on finding cures for leukemia, lymphoma, Hodgkin’s disease and myeloma, while improving the quality of life of patients and their families affected by the burden of these conditions.

In 2013 alone, the society provided nearly $74 million in funding to biomedical research. For this mission, LLS has partnered up with the California Hotel & Lodging Association, a group that includes a series of hotels in the region, and counted with the presence of Tom Klein the Fairmont San Francisco General Manager and Regional Vice-President and CH&LA Board Member, who led the campaign.

The society is open to receive donations to help support their projects, which can be made through their website here.

Inês holds a PhD in Biomedical Sciences from the University of Lisbon, Portugal, where she specialized in blood vessel biology, blood stem cells, and cancer. Before that, she studied Cell and Molecular Biology at Universidade Nova de Lisboa and worked as a research fellow at Faculdade de Ciências e Tecnologias and Instituto Gulbenkian de Ciência. Inês currently works as a Managing Science Editor, striving to deliver the latest scientific advances to patient communities in a clear and accurate manner.
×
Inês holds a PhD in Biomedical Sciences from the University of Lisbon, Portugal, where she specialized in blood vessel biology, blood stem cells, and cancer. Before that, she studied Cell and Molecular Biology at Universidade Nova de Lisboa and worked as a research fellow at Faculdade de Ciências e Tecnologias and Instituto Gulbenkian de Ciência. Inês currently works as a Managing Science Editor, striving to deliver the latest scientific advances to patient communities in a clear and accurate manner.
Latest Posts
  • ATG-019 Phase 1 trial
  • ME-401, FDA fast track
  • Tafasitamab combo, lymphoma
  • blood biomarkers

How useful was this post?

Click on a star to rate it!

Average rating 0 / 5. Vote count: 0

No votes so far! Be the first to rate this post.

As you found this post useful...

Follow us on social media!

We are sorry that this post was not useful for you!

Let us improve this post!

Tell us how we can improve this post?